Introduction
Fumonisins are produced by Fusarium verticillioides (formerly F moniliforme Sheldon) and related Fusarium species. They occur in corn and in corn-based products worldwide and both fumonisins and fumonisin-producing fungi cause toxic effects in animals (Table 1) . Their risk to humans is unclear but both are implicated as factors for esophageal cancer and, more recently, neural tube defects. While much has been learned about fumonisins, research to further characterize their toxicity, their mode of action, as well as to determine their relevance to human health continue. Recent research on some issues of emerging importance is reviewed below. The toxicology and mode of action of fumonisins have been extensively reviewed elsewhere and comprehensive reference lists of original research reports are available in these publications (Table 1) . Fumonisins' mechanism of action is multifaceted but evidence indicates that inhibition of ceramide synthase (fumonisins are structurally similar to the enzyme's sphingoid base substrates sphinganine (Sa) and sphingosine (So)) is the initial mechanistic events. Consequently, sphingolipid metabolism is disrupted and Sa and So accumulate in cells and tissues, cell and tissue complex sphingolipids are depleted, and So (Sa)-1-phosphates and other sphingoid base metabolites accumulate. Consequently, critical sphingolipid-mediated cell signaling pathways or sphingolipid-dependent physiological functions are disrupted. For example, So-1-phosphate binds to G protein-linked Edg receptors and causes vasoconstriction of rat mesenteric and renal microvessels in vitro and in vivo. It is therefore possible that accumulated So-l-phosphate in the kidney of fumonisin-exposed rats might reduce blood flow and exacerbate apoptosis. Likewise, accumulated sphingoid bases in the serum or tissues might be the mechanistic trigger for cardiac insufficiency and, ultimately, pulmonary edema in swine.
Reproductive toxicity revisited
In previous studies, F verticillioides and FB, were not teratogenic to rodents and rabbits and embryotoxicity, when present, occurred only at maternally toxic doses.
However, in several reports, decreased fetal birth weight, and/or increased fetal resorption were found following maternal FB, exposure. Ex utero exposure to FB, caused developmental defects in rat embryos (including exencephaly) but, because 14C-FB, did not cross the placenta of pregnant rats (on Gestation Day 15) and increased Sa or Sa/So (biomarkers of fumonisin exposure)
was not found in fetuses of dams (rats, mice and rabbits) given FB,, it was concluded that the placenta was an effective barrier to in utero exposure.
Fumonisins' potential as a risk factor for birth defects, specifically neural tube defects (cranial and spinal cord abnormalities ranging from spina bifida occulta to exencephaly or craniorhachischisis), has again become a concern. A spike in the incidence of neural tube defects within the Hispanic population near Brownsville, TX in 1990-91, a time when fumonisin levels in locally grown corn were coincidentally high, suggested a possible connection. In this regard, it is interesting to note that neural tube defect incidences are also high in regions of southern Africa, including the Transkei, and elsewhere where fumonisin exposure is likely to be high. Gelineau-van Waes and colleagues have studied maternal exposure and neural tube defects using the inbred LMBc mouse as an in vivo model. In summary, they found dose-dependent increases in neural tube defects (exencephaly) in the litters of dams given intraperitoneal doses of FB, on gestation days 7.5 and 8.5; the incidence of affected fetuses ranged from 2 percent (dose = 5 mg FB,/kg maternal BW) to 79 percent (20 mg/kg). Increased Sa concentration and Sa/So were found not only in the livers and ELEM is unique to Equidae. Liver involvement similar to that in other species also occurs.
Swine
Porcine Pulmonary Edema (PPE): PPE is characterized by rapidly developing accumulations of fluid in alveolar membranes and spaces. Animals subsequently die of respiratory failure. PPE might be the result of compromised cardiac contractility. PPE is unique to swine, but the liver is also a target organ.
Rat
Liver and kidney are the main target organs. Apoptosis is an early finding and with prolonged exposure, necrosis, regenerative and other lesions develop. Serum chemistry findings support the pathology. FB i promotes enzyme (GGT and GST) positive liver foci and is a liver and kidney carcinogen in rats (50 mg/kg in diet), although differences in target organs occurr by sex (male vs. female F344/Nnctr rats) and rat strain (F344/Nnctr males vs BD IX males). Other effects including thymic apoptosis, inhibition or enhancement of immune or host-resistance responses, changes in hepatic gene expression, or indications of oxidative injury have been reported.
Mouse
The liver is the primary target organ in mice. Serum chemistry and pathology findings are consistent with those found in rats and, as in rats, apoptosis and mitosis/regeneration likely play a key role in pathogenesis. The kidney is also a target, but the mouse is not as susceptible as Sprague-Dawley and F344 rats to fumonisin nephrotoxicity. FB 1 (50 mg/kg in the diet) was hepatocarcinogenic to female B6C3F1 mice. Gene knockout strains have been useful for studying how cytokines and various receptors mediate fumonisin toxigenesis. kidneys of the treated dams, but also in their placentas embryos and biodistribution studies confirmed that 14C-FB, crossed the placenta on gestation day 10.5. Why these findings contrast with earlier results' is not known, however, the LMBc studies were done much earlier in gestation, at a time when the placenta is less developed and less likely to provide an effective barrier against mycotoxin exposure. The FB, dose, the route and timing of dosing, or species/strain-related differences in placental physiology, sphingolipid metabolism, and/or genetic susceptibility to neural tube defects are also possible contributing factors. In any event, folate plays a role in the LMBc mouse model. Fetal folate uptake was decreased by FB, and daily oral administration of folinic acid to the high-dose dams (n=10) beginning on the first day of gestation reduced FB,-induced neural tube defect incidence from 79 to 43 percent. Administering the complex sphingolipid ganglioside GM, on gestation days 6.5-9.5 (10 mg/kg/day ip) more effectively counteracted neural tube defect induction by FB,, as the incidence of neural tube defects in the fetuses of dams (n=11) treated with the high-dose of FB, plus GM, was only five percent. Immunohistochemical expression of the folate receptor and ganglioside GM, in the yolk sac membrane and neuroepithelium of the embryos diminished following FB, exposure, also suggesting a connection between sphingolipid depletion and decreased folate transport. These investigations have established the LMBc mouse as a useful model for investigating how fumonisins, sphingolipids, and folate interact to affect neural tube closure. However, given the species/strain-dependent differences in response to fumonisins that occur, more studies in LMBc mice and other mouse strains and species are needed to place these findings in perspective. These include: determining doseresponse and the no observed effect level in LMBc dams exposed to FB, via the diet; determining the influence of maternal toxicity on litter neural tube defect incidence;
investigating transplacental transport of folate and fumonisins as a function of time (gestation day); establishing if folate transport in LMBc dams is uniquely sensitive to FB,; defining more fully the molecular and pathophysiological mechanisms underlying induction of neural tube defects in LMBc mice and, determining the extent to which these mechanistic findings apply to other mouse strains and species.
Cooking and "hidden" fumonisins
There is evidence that "hidden" fumonisins (matrix-bound forms not detected using "routine" extraction and analysis methods) are present in some foods (Table 2) .
Fumonisin-matrix interactions and reaction products in foods are not well characterized.
Several have been detected (Table 2 ) and others are possible. When extracted (using a "routine" method) cornflake residues were re -extracted with sodium dodecyl sulfate and the second extract then base hydrolysed, a significant amount (2.6 times the amount and toxicity to rats of FB 1-glucose reaction product(s) was reduced compared to FB 1 possibly due to limited bioavailability of the fumonisin-sugar compound, lack of a free amino function on the reaction product, or both. These compounds are measured using mass spectroscopy or other methods not dependent on derivatization of the amino group.
3-keto fumonisins 3-keto FB1 was formed by ozonation (a candidate detoxification method) of an aqueous FB 1 solution. 3-keto FB 1 retains biological activity but its toxicity has not been tested in vivo in mammalian or avian species. 3-keto FB 1 can be quantified by routine HPLC or mass spectrometry methods.
Deaminated fumonisins

Deaminated
FB 1 is formed by reaction of FB 1 with NaNO2. Deaminated FB i was not toxic to Hydra and did not inhibit ceramide synthase in vitro. Bioavailability and toxicity has not been tested in mammals. The deaminated product can be quantified using mass spectrometry but the loss of the amino group precludes detection of the deamination product using "routine" HPLC methods for fumonisins.
Fumonisinstarch & protein conjugates
Heating FB1, with sucrose, methyl a-D-glucosylpyranoside (a starch model), or N-a-acetyl-L-lysine methyl ester and BOC-L-cysteine methyl ester (protein surrogates), yielded conjugation products. In contrast to FB1-reducing sugar products, the sugar (or amino acid) bound to the tricarballylic acid function of FB 1. It is possible that conjugated fumonisins could become bioavailable by hydrolysis of the conjugated product during digestion. Analysis is difficult but can be indirectly accomplished by HPLC or mass spectrometric analysis of hydrolyzed fumonisins after base hydrolysis of the food or grain sample 16). It is possible that these might contribute to "hidden" fumonisins in some foods. measured initially) of "hidden" fumonisins was liberated. The toxicological importance of these "hidden" fumonisins in foods depends upon their concentration, bioavailability, and inherent toxicity. Cooking variably reduces measurable fumonisins in foods and consequently might reduce toxicity. For example, cooking in water significantly reduced both fumonisin concentration (ca. 90 %) and in vivo toxicity to rats of F verticillioides molded corn. Nixtamalization (cooking/steeping in alkaline water) extracts fumonisins from corn and reduces their amounts in masa and tortilla products by as much as 80 percent.
The fate of the remaining fumonisins, originally present in the corn, was not determined in these experiments but only trace amounts of Maillard reaction products (see explanation in Table 2 ) were detected in the masa. In addition to Maillard reaction products, fumonisin-starch or -protein conjugates can be formed by reactions involving fumonisin's tricarballylic acid groups. This has potentially important toxicological implications because these compounds are not readily detected by routine analytical procedures and also because they might break down in the intestines, liberating free fumonisin. The possible formation of unknown toxic fumonisin reaction products during cooking must also be considered.
To circumvent any analytical uncertainty, the effect of cooking on fumonisin toxicity was evaluated using an in vivo bioassay. Briefly, pan-fried corncakes, deepfried fritters, and baked cornbread were made from cornmeal that was spiked with F verticillioides culture material. The cooked products, uncooked spiked cornmeal, or uncontaminated cornmeal (high dose only) were fed to rats at a low (2 % w/w mixed into rodent chow) or high (20 % w/w) doses for two weeks. The toxic effects induced by the cooked products and the uncooked spiked cornmeal, as determined by microscopic evaluation of liver and kidneys, were indistinguishable and typical of those caused by fumonisins. Measured fumonisin (FB1 + FL2; HPLC analysis) concentrations of the highdose pan-fried corncake diet (92 mg/kg) were 30 percent less than that of the high-dose uncooked spiked cornmeal diet (131 mg/kg) but baking and deep-frying had essentially no effect on fumonisin concentration (120-132 mg/kg in the products). It could not be concluded that any "hidden" or unknown fumonisins formed during pan-frying because, at the dose levels used in the study, a 30 % reduction in fumonisin concentration is unlikely to affect dose-response. Importantly, however, the results indicated that baking and frying did not enhance toxicity. More investigations are needed to further elucidate how various cooking methods and recipes affect chemical fate and toxicity of fumonisins, especially in foods prepared from naturally contaminated corn having low (<5 mg/kg) fumonisin concentrations, and to optimize cooking conditions to reduce fumonisins in food products.
Prospects for detoxification
Strategies for reducing fumonisins in foods include controlling the growth of mycotoxigenic fungi in the field. In this regard, breeding programs to produce hybrid plants that do not accumulate fumonisins or competitive exclusion using fumonisin non-producing fungi or nontoxic bacteria might be effective. Developing transgenic plants that resist insect damage caused by corn borers and earworms might also prove to be useful, however, none of these approaches have yet been developed into a management program proven to reduce F verticillioides or fumonisins in corn under field conditions.
Chemical and physical treatments for detoxifying fumonisins have produced variable success (Table 2 ). Ammoniation using a procedure effective for reducing aflatoxin in corn was ineffective against fumonisins. Ozone treatment was likewise ineffective against FB 1 as the reaction product, a 3-keto FB 1, was biologically active. On the other hand, FB1-reducing sugar reaction (Maillard reaction) products were not toxic to rats or mice. The addition of glucose to cornmeal or grits likewise decreased the amount of FB 1 measured in baked and extruded foods but the reaction products have not been characterized. Significant amounts of N (carboxymethyl)-FB1 were not detected and the presence or absence of N (deoxy-D-fructos-l-yl)-FB 1 or fumonisin-sugar (protein) conjugates was not reported. 
